Skip to main content
. 2018 Jul 23;8(3):e28. doi: 10.5415/apallergy.2018.8.e28

Table 3. Safety of oral immunotherapy during maintenance.

Allergic reaction & symptom No.
Allergic reactions
<3 episodes 16
≥3 episodes 3
No allergic reactions 23
Symptoms
Mucocutaneous 17
Respiratory 7
Gastrointestinal 3
Systemic reactions (at least 2 systems involved) 2
Headaches 1